Evaluation of Extended Interval Dosing Aminoglycosides in the Morbidly Obese Population

Table 3

Patient pharmacokinetic parameters when two concentrations were available.

	Elimination rate (H^−1)	Volume of distribution (L/kg)	Half-life (Hrs)	𝐶max (mg/dL)	𝐶min (mg/dL)
Patient 1	0.149	0.23	4.6	19.6	0.6
Patient 2	0.156	0.29	4.4	16.8	0.4
Patient 3	0.158	0.29	4.4	22.6	0.5